Summary & Overview
CPT 95811: Polysomnography with PAP Initiation, Attended
CPT 95811 represents an attended polysomnography study that combines comprehensive sleep staging with multiple physiologic channels and the initiation of positive airway pressure therapy during the recording. This procedure is a key tool in diagnosing complex sleep-disordered breathing and initiating treatment during a single monitored night, making it clinically and operationally significant across the United States. Major national payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the code, common billing and site-of-service considerations, and how CPT 95811 relates to adjacent polysomnography codes used for differing monitoring scopes and patient ages. The publication outlines billing nuances such as typical facility settings, common usage scenarios in sleep medicine and neurology practices, and links to related procedure codes for comparative context. It also highlights coding attributes relevant to payers and providers without issuing clinical recommendations. Data not available in the input for certain operational metrics (for example, service line metadata) is noted where applicable.
CPT Code Overview
CPT 95811 describes an attended polysomnography procedure that includes sleep staging with four or more additional physiologic parameters and the initiation of continuous positive airway pressure (CPAP) or bilevel ventilation during the study. This service is performed in the context of Sleep Medicine / Neurology and is typically delivered in a facility-based sleep laboratory setting (for example, POS 22 or POS 11). The procedure is attended by a technologist throughout the recording and is intended to document sleep architecture while initiating PAP therapy as part of the diagnostic and therapeutic evaluation.
Clinical & Coding Specifications
Clinical Context
A middle-aged adult with excessive daytime sleepiness, loud snoring, and witnessed apneas is referred to a sleep laboratory for attended in-lab polysomnography with auto-titration of positive airway pressure. The patient arrives in the evening and is evaluated by a sleep technologist and ordering sleep medicine physician. Standard sensors are applied for electroencephalography, electrooculography, electromyography, airflow, respiratory effort, oxygen saturation, and body position. During the study, diagnostic sleep staging is performed with four or more additional physiological parameters and continuous positive airway pressure (CPAP) therapy or bilevel ventilation is initiated and adjusted by the technologist under physician protocol. Monitoring continues until an adequate therapeutic response is achieved or the study is completed; results are reviewed by the interpreting physician and a report is generated for the referring provider.
Coding Specifications
-
Modifier
52: Reduced services – use when less than 6 hours of recording or for reduced services in polysomnography, per CMS billing guidance. -
Provider Taxonomies and Specialties:
| Taxonomy Code | Specialty |
|---|---|
207RS0012X | Sleep Medicine Physician |
207L00000X | Anesthesiology Physician |
207Q00000X | Family Medicine Physician |
207R00000X | Internal Medicine Physician |
2084P0800X | Psychiatry Physician |
-
Notes on use:
-
Use
52when the polysomnography recording is intentionally reduced below standard duration or otherwise modified per payer guidance. -
If professional vs technical components are relevant, use the appropriate modifiers consistent with payer policy (not listed in input).
Related Diagnoses
-
G47.31— Primary central sleep apnea- Clinical relevance: Central sleep apnea is a primary indication for diagnostic and attended polysomnography with possible initiation of positive airway pressure or bilevel ventilation when central events are identified.
-
G47.33— Obstructive sleep apnea (adult) (pediatric)- Clinical relevance: Obstructive sleep apnea is a common indication for polysomnography and for initiation/titration of CPAP or bilevel therapy during an attended sleep study.
-
G47.34— Idiopathic sleep related nonobstructive alveolar hypoventilation- Clinical relevance: Hypoventilation disorders may be evaluated with extended physiologic monitoring during polysomnography and may require initiation of ventilatory support.
-
G47.35— Congenital central alveolar hypoventilation syndrome- Clinical relevance: Congenital central hypoventilation is a condition requiring specialized sleep lab evaluation and possible initiation of ventilatory support during polysomnography.
-
G47.36— Sleep related hypoventilation in conditions classified elsewhere- Clinical relevance: Hypoventilation associated with other diseases can be assessed during polysomnography to determine need for positive pressure ventilation.
-
G47.37— Central sleep apnea in conditions classified elsewhere- Clinical relevance: Central sleep apnea secondary to other conditions is evaluated with attended polysomnography and may prompt initiation of bilevel ventilation.
-
G47.39— Other sleep apnea- Clinical relevance: Other forms of sleep apnea identified clinically are indications for attended polysomnography and potential initiation of PAP therapy.
Related CPT Codes
| CPT Code | Description |
|---|---|
95782 | Polysomnography; younger than 6 years, sleep staging with 4 or more additional parameters of sleep, attended by a technologist |
95808 | Polysomnography; sleep staging with 1–3 additional parameters of sleep, attended by a technologist |
95810 | Polysomnography; sleep staging with 4 or more additional parameters of sleep, attended by a technologist |
-
95782is the age-specific CPT used for children younger than 6 years when attended polysomnography with multiple parameters and technologist attendance is performed; it is an alternative to adult codes for pediatric patients. -
95808represents studies with fewer additional physiologic parameters (1–3) and is an alternative when fewer channels are recorded compared with the primary code. -
95810is closely related and represents attended polysomnography with 4 or more additional parameters without initiation of positive airway pressure; it may be used for diagnostic studies when PAP initiation is not performed.95810and95811are alternative or sequential codes depending on whether PAP or bilevel ventilation initiation occurs during the attended study.
National Reimbursement Benchmarks
Across national payers, Medicare's mean allowed rate of $492.41 is lower than the BUCA (combined commercial) mean of $605.68 for 95811, indicating Medicare reimburses below the average commercial level. The commercial payer means range from $536.53 (Aetna) up to $736.48 (Cigna), with BUCA sitting near the middle of that commercial distribution.
Dispersion measured as the difference between the 75th and 25th percentiles varies notably by payer. Medicare shows a wide spread (700.50 - 129.50 = $571.00), indicating the largest dispersion, while Aetna (615.33 - 424.73 = $190.60) and BCBS (664.56 - 400.00 = $264.56) are comparatively tighter; Cigna (901.33 - 523.00 = $378.33) and UnitedHealth Group (827.50 - 501.10 = $326.40) are intermediate. The table and chart below present the full breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.